A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2572 participants.
Also called NCT03066804
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,572 participants
- Sponsor
- Registry
-
NCT03066804 -
2016-003410-28
-
- Other papers using this trial's data
- Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hungary, India, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, Peru, Portugal, Romania, Russia, Serbia, Slovakia, Spain, Thailand, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03066804. Randomized; quadruple masking; primary purpose treatment. Start 2017-08-22 (actual); primary completion 2019-10-28 (actual). Results posted on 2021-02-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
- Acronym
- PARALLAX
- Intervention (Drug)
- sacubitril/valsartan
- Intervention (Drug)
- Enalapril
- Intervention (Drug)
- Valsartan
- Intervention (Drug)
- Placebo to match sacubitril/valsartan
- Intervention (Drug)
- Placebo to match enalapril
- Intervention (Drug)
- Placebo to match valsartan
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct03066804- Content hash
f94ccf9799aa3711e9a8b9ee77ac19243202ef59d83cf4e71998f7a5661b0ce6